View Future GrowthDaicel 과거 순이익 실적과거 기준 점검 1/6Daicel은 연평균 6.5%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 수입이 4% 감소했습니다. 매출은 연평균 6.7%의 비율로 증가했습니다. Daicel의 자기자본이익률은 3.1%이고 순이익률은 1.8%입니다.핵심 정보6.50%순이익 성장률8.92%주당순이익(EPS) 성장률Chemicals 산업 성장률12.93%매출 성장률6.72%자기자본이익률3.09%순이익률1.76%최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트공시 • Feb 06Daicel Corporation to Report Fiscal Year 2026 Results on May 12, 2026Daicel Corporation announced that they will report fiscal year 2026 results on May 12, 2026공시 • Nov 11Daicel Corporation to Report Q3, 2026 Results on Feb 05, 2026Daicel Corporation announced that they will report Q3, 2026 results on Feb 05, 2026공시 • Aug 05Daicel Corporation to Report Q2, 2026 Results on Nov 06, 2025Daicel Corporation announced that they will report Q2, 2026 results on Nov 06, 2025공시 • May 16Daicel Corporation to Report Q1, 2026 Results on Aug 01, 2025Daicel Corporation announced that they will report Q1, 2026 results on Aug 01, 2025공시 • Feb 08Daicel Corporation to Report Fiscal Year 2025 Results on May 13, 2025Daicel Corporation announced that they will report fiscal year 2025 results on May 13, 2025공시 • Nov 30Daicel Corporation to Report Q3, 2025 Results on Feb 05, 2025Daicel Corporation announced that they will report Q3, 2025 results on Feb 05, 2025모든 업데이트 보기Recent updates공시 • May 12Daicel Corporation, Annual General Meeting, Jun 19, 2026Daicel Corporation, Annual General Meeting, Jun 19, 2026.공시 • Mar 10Denka Company Limited (TSE:4061) enter into a share transfer agreement to acquire an additional 15% stake in Toyo Styrene Co. Ltd from Daicel Corporation (TSE:4202).Denka Company Limited (TSE:4061) enter into a share transfer agreement to acquire an additional 15% stake in Toyo Styrene Co. Ltd from Daicel Corporation (TSE:4202) on March 9, 2026. Upon completion, Denka Company Limited will own 65% stake in Toyo Styrene Co. Ltd. As a result of this transaction, Toyo Styrene is expected to become a consolidated subsidiary of the Company that qualifies as a specified subsidiary. Daicel will cease to be a co-investor in Toyo Styrene, and Toyo Styrene’s Hirohata Plant will be shut down. For a certain period, however, Toyo Styrene will continue to outsource production to Daicel and maintain product sales. For the period ending March 31, 2025, Toyo Styrene Co. Ltd reported total revenue of ¥48.39 billion, EBIT of ¥1.22 billion and net income of ¥788 million. As of March 31, 2025, Toyo Styrene Co. Ltd reported total assets of ¥27.69 billion and total common equity of ¥11.73 billion. The completion of this share transfer is subject to the completion of the necessary approvals, permissions, or clearances from the relevant authorities in accordance with the Anti-Monopoly Act and other applicable laws and regulations. The expected completion of the transaction is March 31, 2026.공시 • Feb 06Daicel Corporation to Report Fiscal Year 2026 Results on May 12, 2026Daicel Corporation announced that they will report fiscal year 2026 results on May 12, 2026공시 • Nov 11Daicel Corporation to Report Q3, 2026 Results on Feb 05, 2026Daicel Corporation announced that they will report Q3, 2026 results on Feb 05, 2026공시 • Nov 06Daicel Corporation (TSE:4202) announces an Equity Buyback for 11,000,000 shares, representing 4.14% for ¥15,000 million.Daicel Corporation (TSE:4202) announces a share repurchase program. Under the program, the company will repurchase up to 11,000,000 shares, representing 4.14% of its issued share capital, for a total purchase price of ¥15,000 million. The purpose of the program is to enhance shareholder returns and improve capital efficiency as part of the capital policy in the medium-term strategy. The program will be valid till March 31, 2026. As of September 30, 2025, the company had 265,496,681 issued shares (excluding treasury stock) and 1,446,001 treasury shares.공시 • Oct 17Daicel Corporation Announces Reorganization Plan Involving A Company Split with A Consolidated SubsidiaryAt a meeting of its Board of Directors held on October 16, 2025, Daicel Corporation resolved to proceed with consideration of a policy under which the Company will succeed to all businesses of its consolidated subsidiary, Polyplastics Co. Ltd. ("Polyplastics"), by way of an absorption-type company split (the "Absorption-type Company Split"). The business to be succeeded (the "Target Business") excludes the business of holding and managing shares of subsidiaries and affiliates owned by Polyplastics. In accordance with the Policy, the Company plans to formally decide on absorption-type company split (the "Absorption-type Company Split") at its Board of Directors meeting scheduled for January 15, 2026, and will make a further timely disclosure at that time. As the Absorption-type Company Split is expected to be a simplified absorption-type company split involving a consolidated subsidiary, certain disclosure items and details have been omitted. In line with the Company's medium-term strategy "Accelerate 2025", Daicel has been working to transform its business structure and further strengthen its engineering plastics business. As part of this initiative, the Company made Polyplastics a wholly owned subsidiary in 2020. Since then, Polyplastics has promptly decided and executed investments to expand the capacity of its overseas manufacturing bases, including the commencement of the POM production facilities in China. In terms of business performance as well, Polyplastics achieved record-high consolidated profits in the previous fiscal year, demonstrating the tangible benefits of becoming a wholly owned subsidiary. With the Absorption-type Company Split, the Company aims to create a "New Daicel" by integrating the Target Business of Polyplastics into the Company. Through (i) sharing of technical service and solution-provision know-how, which represents Polyplastics' core strengths, (ii) enhancing collaboration with the Company's Safety, Materials and other businesses, (iii) utilization of human resources for the growth of the group as a whole, and (iv) improving the efficiency of corporate functions, the Company seeks to maximize corporate value.공시 • Aug 05Daicel Corporation to Report Q2, 2026 Results on Nov 06, 2025Daicel Corporation announced that they will report Q2, 2026 results on Nov 06, 2025공시 • May 16Daicel Corporation to Report Q1, 2026 Results on Aug 01, 2025Daicel Corporation announced that they will report Q1, 2026 results on Aug 01, 2025공시 • May 13+ 3 more updatesDaicel Corporation, Annual General Meeting, Jun 20, 2025Daicel Corporation, Annual General Meeting, Jun 20, 2025.공시 • Apr 02Daicel Corporation (TSE:4202) agreed to acquire remaining 65% stake in Toyama Filter Tow Co., Ltd. from Mitsubishi Chemical Corporation.Daicel Corporation (TSE:4202) agreed to acquire remaining 65% stake in Toyama Filter Tow Co., Ltd. from Mitsubishi Chemical Corporation on March 31, 2025. Upon completion, Daicel Corporation will own 100% stake in Toyama Filter Tow Co., Ltd. The transaction is expected to close on April 1, 2025.공시 • Feb 08Daicel Corporation to Report Fiscal Year 2025 Results on May 13, 2025Daicel Corporation announced that they will report fiscal year 2025 results on May 13, 2025공시 • Nov 30Daicel Corporation to Report Q3, 2025 Results on Feb 05, 2025Daicel Corporation announced that they will report Q3, 2025 results on Feb 05, 2025공시 • Nov 07+ 1 more updateDaicel Corporation Declares Dividend for the Second Quarter End of the Fiscal Year 2025, Payable on December 3, 2024; Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2025Daicel Corporation declared dividend of JPY 30.00 per share for the second quarter end of fiscal year ending March 31, 2025. Scheduled date of payment is December 3, 2024. Record date is September 30, 2024. The company revised year end dividend guidance for the fiscal year ending March 31, 2025. For the period, the company expects to pay dividend of JPY 30.00 per share against the previous guidance of JPY 28.00 per share. Reasons for the revision of Interim Dividend and Year-end Dividend Forecast: In Mid-Term Management Strategy "Accelerate 2025" (from the fiscal year ended March 2021 to the fiscal year ending March 2026), are targeting a total return ratio of 40% or more, which is a combination of dividends and agile share buybacks. In addition, starting from this fiscal year (ending March 31, 2025), in order to clarify commitment to providing stable dividends, have added a new target of a DOE (dividend on equity) ratio of 4% or more in addition to total return ratio. Although have revised full-year consolidated earnings forecast downward this time, excluding one-off losses such as the impact of plant trouble, earnings are higher than the figures previously announced, and taking into consideration steadily improving cash generation capabilities, have decided to revise interim dividend to ¥30 per share (an increase of ¥3 per share from the original forecast). In addition, have decided to revise the payment of the year-end dividend to ¥30 per share, an increase of ¥2 per share from the previous forecast which bring the annual dividend to ¥60 per share. As a result, the annual dividend forecast will be ¥60, the DOE ratio will be 4.5%, and together with the share buyback announced, the total return ratio is expected to be 61.2%.공시 • Aug 27Daicel Corporation to Report Q2, 2025 Results on Nov 07, 2024Daicel Corporation announced that they will report Q2, 2025 results on Nov 07, 2024공시 • Jun 28Daicel Corporation to Report Q1, 2025 Results on Aug 02, 2024Daicel Corporation announced that they will report Q1, 2025 results on Aug 02, 2024공시 • May 11Daicel Corporation, Annual General Meeting, Jun 21, 2024Daicel Corporation, Annual General Meeting, Jun 21, 2024.공시 • May 10+ 1 more updateDaicel Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2024 and Fiscal Year Ending March 31, 2025Daicel Corporation provided consolidated earnings guidance for the six months ending September 30, 2024 and fiscal year ending March 31, 2025. For the six months, the company expects net sales of JPY 295,000 million, operating profit of JPY 32,000 million, profit attributable to owners of parent of JPY 30,000 million and profit per share of JPY 108.77.For the full year, the company expects net sales of JPY 610,000 million, operating profit of JPY 65,000 million, profit attributable to owners of parent of JPY 58,000 million and profit per share of JPY 210.29.공시 • Mar 28Daicel Corporation to Report Fiscal Year 2024 Results on May 09, 2024Daicel Corporation announced that they will report fiscal year 2024 results on May 09, 2024공시 • Nov 27Daicel Corporation to Report Q3, 2024 Results on Feb 06, 2024Daicel Corporation announced that they will report Q3, 2024 results on Feb 06, 2024공시 • Nov 03+ 1 more updateDaicel Corporation (TSE:4202) announces an Equity Buyback for 13,000,000 shares, representing 4.55% for ¥15,000 million.Daicel Corporation (TSE:4202) announces a share repurchase program. Under the program, the company will repurchase up to 13,000,000 shares, representing 4.55% of its issued share capital (excluding treasury stock), for a total purchase price of ¥15,000 million. The purpose of the program is to enhance shareholder returns and improve capital efficiency. The program will be valid till March 31, 2024. As of September 30, 2023, the company had 285,955,394 issued shares (excluding treasury stock) and 987,288 treasury shares.공시 • Nov 02Daicel Corporation Declares Dividend for the Second Quarter End of the Fiscal Year 2024, Payable on December 4, 2023; Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024Daicel Corporation declared dividend of JPY 25.00 per share for the second quarter end of fiscal year ending March 31, 2024. Scheduled date of payment is December 4, 2023. Record date is September 30, 2023.The company revised year end dividend guidance for the fiscal year ending March 31, 2024. For the period, the company expects to pay dividend of JPY 25.00 per share against the previous guidance of JPY 22.00 per share.공시 • Sep 24Daicel Corporation to Report Q2, 2024 Results on Nov 02, 2023Daicel Corporation announced that they will report Q2, 2024 results on Nov 02, 2023공시 • Sep 22Pharma Foods International Co., Ltd. (TSE:2929) agreed to acquire Healthcare Mail Order Business Of Daicel from Daicel Corporation (TSE:4202).Pharma Foods International Co., Ltd. (TSE:2929) agreed to acquire Healthcare Mail Order Business Of Daicel from Daicel Corporation (TSE:4202) on September 20, 2023.공시 • Jun 28Daicel Corporation to Report Q1, 2024 Results on Aug 03, 2023Daicel Corporation announced that they will report Q1, 2024 results on Aug 03, 2023공시 • May 12+ 1 more updateDaicel Corporation Announces Year End Dividend for the Year Ended March 31, 2023, Payable on June 26, 2023; Provides Dividend Guidance for the End of Second Quarter and Full Year Ending March 31, 2024Daicel Corporation announced year end dividend of JPY 20.00 per share for the year ended March 31, 2023 compared to JPY 18.00 per share a year ago. Scheduled date for dividend payment: June 26, 2023. The company provided dividend guidance for the end of second quarter and full year ending March 31, 2024. For the end of second quarter, the company expects to pay dividend of JPY 22.00 per share compared to JPY 18.00 per share a year ago. For the full year ending March 31, 2024, the company expects to pay dividend of JPY 22.00 per share compared to JPY 20.00 per share a year ago.공시 • May 11Daicel Corporation, Annual General Meeting, Jun 23, 2023Daicel Corporation, Annual General Meeting, Jun 23, 2023.공시 • Feb 03+ 1 more updateDaicel Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023Daicel Corporation provided consolidated earnings guidance for the year ending March 31, 2023. For the year ending March 31, 2023, the company expects net sales of JPY 579,000 million, operating profit of JPY 54,000 million and profit attributable to owners of parent of JPY 41,000 or JPY 138.44 per share.공시 • Feb 02Daicel Corporation to Report Fiscal Year 2023 Results on May 11, 2023Daicel Corporation announced that they will report fiscal year 2023 results on May 11, 2023공시 • Dec 28Daicel Corporation to Report Q3, 2023 Results on Feb 02, 2023Daicel Corporation announced that they will report Q3, 2023 results on Feb 02, 2023매출 및 비용 세부 내역Daicel가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OTCPK:DACH.F 매출, 비용 및 순이익 (JPY Millions)날짜매출순이익일반관리비연구개발비31 Mar 26579,62910,180104,219031 Dec 25578,81041,141103,250030 Sep 25573,96236,22978,44024,83930 Jun 25580,22942,911104,580031 Mar 25586,53149,48078,89624,83931 Dec 24576,32555,66780,72122,28630 Sep 24576,74058,13678,66922,28630 Jun 24572,82657,03976,07322,28631 Mar 24558,05655,83474,60122,28631 Dec 23547,78955,34374,95920,64630 Sep 23542,79848,22375,92320,64630 Jun 23540,84746,76377,02420,64631 Mar 23538,02640,68277,65720,64631 Dec 22529,47137,30079,03519,66730 Sep 22509,35231,41875,63019,66730 Jun 22484,56027,87471,95619,66731 Mar 22467,93731,25468,24319,66731 Dec 21455,18831,98166,90018,56730 Sep 21443,03938,48665,53418,56730 Jun 21422,01331,36163,74818,56731 Mar 21393,56819,71361,14118,56731 Dec 20381,39411,56557,94620,32830 Sep 20377,491-3,43258,57420,32830 Jun 20391,85529159,84320,32831 Mar 20412,8264,97861,07820,32831 Dec 19420,7146,87363,31419,69030 Sep 19440,29824,59063,55119,69030 Jun 19453,22130,21463,40219,69031 Mar 19464,85935,30162,91219,69031 Dec 18474,18941,65663,24218,01530 Sep 18469,16339,87561,96418,01530 Jun 18466,19738,36160,87118,01531 Mar 18462,95637,06260,25418,01531 Dec 17463,05039,38861,37816,11730 Sep 17459,29443,72059,97616,11730 Jun 17448,64641,74658,32616,11731 Mar 17440,06143,19856,40916,11731 Dec 16430,45038,73355,72314,63830 Sep 16433,19238,02655,12814,63830 Jun 16440,13139,23355,13114,63831 Mar 16449,87840,31354,84114,63831 Dec 15452,85139,11069,259030 Sep 15451,57535,64068,282030 Jun 15448,71433,73966,4960양질의 수익: DACH.F는 ¥19.0B 규모의 큰 일회성 손실이 있어 31st March, 2026까지 지난 12개월 재무 결과에 영향을 미쳤습니다.이익 마진 증가: DACH.F의 현재 순 이익률 (1.8%)은 지난해 (8.4%)보다 낮습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: DACH.F의 수익은 지난 5년 동안 연평균 6.5% 증가했습니다.성장 가속화: DACH.F은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: DACH.F은 지난 1년 동안 수익이 감소(-79.4%)하여 Chemicals 업계 평균(0.1%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: DACH.F의 자본 수익률(3.1%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/02 04:01종가2026/05/11 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Daicel Corporation는 17명의 분석가가 다루고 있습니다. 이 중 7명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Mikiya YamadaBarclaysTakashi EnomotoBofA Global ResearchSze TeeCGS International14명의 분석가 더 보기
공시 • Feb 06Daicel Corporation to Report Fiscal Year 2026 Results on May 12, 2026Daicel Corporation announced that they will report fiscal year 2026 results on May 12, 2026
공시 • Nov 11Daicel Corporation to Report Q3, 2026 Results on Feb 05, 2026Daicel Corporation announced that they will report Q3, 2026 results on Feb 05, 2026
공시 • Aug 05Daicel Corporation to Report Q2, 2026 Results on Nov 06, 2025Daicel Corporation announced that they will report Q2, 2026 results on Nov 06, 2025
공시 • May 16Daicel Corporation to Report Q1, 2026 Results on Aug 01, 2025Daicel Corporation announced that they will report Q1, 2026 results on Aug 01, 2025
공시 • Feb 08Daicel Corporation to Report Fiscal Year 2025 Results on May 13, 2025Daicel Corporation announced that they will report fiscal year 2025 results on May 13, 2025
공시 • Nov 30Daicel Corporation to Report Q3, 2025 Results on Feb 05, 2025Daicel Corporation announced that they will report Q3, 2025 results on Feb 05, 2025
공시 • May 12Daicel Corporation, Annual General Meeting, Jun 19, 2026Daicel Corporation, Annual General Meeting, Jun 19, 2026.
공시 • Mar 10Denka Company Limited (TSE:4061) enter into a share transfer agreement to acquire an additional 15% stake in Toyo Styrene Co. Ltd from Daicel Corporation (TSE:4202).Denka Company Limited (TSE:4061) enter into a share transfer agreement to acquire an additional 15% stake in Toyo Styrene Co. Ltd from Daicel Corporation (TSE:4202) on March 9, 2026. Upon completion, Denka Company Limited will own 65% stake in Toyo Styrene Co. Ltd. As a result of this transaction, Toyo Styrene is expected to become a consolidated subsidiary of the Company that qualifies as a specified subsidiary. Daicel will cease to be a co-investor in Toyo Styrene, and Toyo Styrene’s Hirohata Plant will be shut down. For a certain period, however, Toyo Styrene will continue to outsource production to Daicel and maintain product sales. For the period ending March 31, 2025, Toyo Styrene Co. Ltd reported total revenue of ¥48.39 billion, EBIT of ¥1.22 billion and net income of ¥788 million. As of March 31, 2025, Toyo Styrene Co. Ltd reported total assets of ¥27.69 billion and total common equity of ¥11.73 billion. The completion of this share transfer is subject to the completion of the necessary approvals, permissions, or clearances from the relevant authorities in accordance with the Anti-Monopoly Act and other applicable laws and regulations. The expected completion of the transaction is March 31, 2026.
공시 • Feb 06Daicel Corporation to Report Fiscal Year 2026 Results on May 12, 2026Daicel Corporation announced that they will report fiscal year 2026 results on May 12, 2026
공시 • Nov 11Daicel Corporation to Report Q3, 2026 Results on Feb 05, 2026Daicel Corporation announced that they will report Q3, 2026 results on Feb 05, 2026
공시 • Nov 06Daicel Corporation (TSE:4202) announces an Equity Buyback for 11,000,000 shares, representing 4.14% for ¥15,000 million.Daicel Corporation (TSE:4202) announces a share repurchase program. Under the program, the company will repurchase up to 11,000,000 shares, representing 4.14% of its issued share capital, for a total purchase price of ¥15,000 million. The purpose of the program is to enhance shareholder returns and improve capital efficiency as part of the capital policy in the medium-term strategy. The program will be valid till March 31, 2026. As of September 30, 2025, the company had 265,496,681 issued shares (excluding treasury stock) and 1,446,001 treasury shares.
공시 • Oct 17Daicel Corporation Announces Reorganization Plan Involving A Company Split with A Consolidated SubsidiaryAt a meeting of its Board of Directors held on October 16, 2025, Daicel Corporation resolved to proceed with consideration of a policy under which the Company will succeed to all businesses of its consolidated subsidiary, Polyplastics Co. Ltd. ("Polyplastics"), by way of an absorption-type company split (the "Absorption-type Company Split"). The business to be succeeded (the "Target Business") excludes the business of holding and managing shares of subsidiaries and affiliates owned by Polyplastics. In accordance with the Policy, the Company plans to formally decide on absorption-type company split (the "Absorption-type Company Split") at its Board of Directors meeting scheduled for January 15, 2026, and will make a further timely disclosure at that time. As the Absorption-type Company Split is expected to be a simplified absorption-type company split involving a consolidated subsidiary, certain disclosure items and details have been omitted. In line with the Company's medium-term strategy "Accelerate 2025", Daicel has been working to transform its business structure and further strengthen its engineering plastics business. As part of this initiative, the Company made Polyplastics a wholly owned subsidiary in 2020. Since then, Polyplastics has promptly decided and executed investments to expand the capacity of its overseas manufacturing bases, including the commencement of the POM production facilities in China. In terms of business performance as well, Polyplastics achieved record-high consolidated profits in the previous fiscal year, demonstrating the tangible benefits of becoming a wholly owned subsidiary. With the Absorption-type Company Split, the Company aims to create a "New Daicel" by integrating the Target Business of Polyplastics into the Company. Through (i) sharing of technical service and solution-provision know-how, which represents Polyplastics' core strengths, (ii) enhancing collaboration with the Company's Safety, Materials and other businesses, (iii) utilization of human resources for the growth of the group as a whole, and (iv) improving the efficiency of corporate functions, the Company seeks to maximize corporate value.
공시 • Aug 05Daicel Corporation to Report Q2, 2026 Results on Nov 06, 2025Daicel Corporation announced that they will report Q2, 2026 results on Nov 06, 2025
공시 • May 16Daicel Corporation to Report Q1, 2026 Results on Aug 01, 2025Daicel Corporation announced that they will report Q1, 2026 results on Aug 01, 2025
공시 • May 13+ 3 more updatesDaicel Corporation, Annual General Meeting, Jun 20, 2025Daicel Corporation, Annual General Meeting, Jun 20, 2025.
공시 • Apr 02Daicel Corporation (TSE:4202) agreed to acquire remaining 65% stake in Toyama Filter Tow Co., Ltd. from Mitsubishi Chemical Corporation.Daicel Corporation (TSE:4202) agreed to acquire remaining 65% stake in Toyama Filter Tow Co., Ltd. from Mitsubishi Chemical Corporation on March 31, 2025. Upon completion, Daicel Corporation will own 100% stake in Toyama Filter Tow Co., Ltd. The transaction is expected to close on April 1, 2025.
공시 • Feb 08Daicel Corporation to Report Fiscal Year 2025 Results on May 13, 2025Daicel Corporation announced that they will report fiscal year 2025 results on May 13, 2025
공시 • Nov 30Daicel Corporation to Report Q3, 2025 Results on Feb 05, 2025Daicel Corporation announced that they will report Q3, 2025 results on Feb 05, 2025
공시 • Nov 07+ 1 more updateDaicel Corporation Declares Dividend for the Second Quarter End of the Fiscal Year 2025, Payable on December 3, 2024; Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2025Daicel Corporation declared dividend of JPY 30.00 per share for the second quarter end of fiscal year ending March 31, 2025. Scheduled date of payment is December 3, 2024. Record date is September 30, 2024. The company revised year end dividend guidance for the fiscal year ending March 31, 2025. For the period, the company expects to pay dividend of JPY 30.00 per share against the previous guidance of JPY 28.00 per share. Reasons for the revision of Interim Dividend and Year-end Dividend Forecast: In Mid-Term Management Strategy "Accelerate 2025" (from the fiscal year ended March 2021 to the fiscal year ending March 2026), are targeting a total return ratio of 40% or more, which is a combination of dividends and agile share buybacks. In addition, starting from this fiscal year (ending March 31, 2025), in order to clarify commitment to providing stable dividends, have added a new target of a DOE (dividend on equity) ratio of 4% or more in addition to total return ratio. Although have revised full-year consolidated earnings forecast downward this time, excluding one-off losses such as the impact of plant trouble, earnings are higher than the figures previously announced, and taking into consideration steadily improving cash generation capabilities, have decided to revise interim dividend to ¥30 per share (an increase of ¥3 per share from the original forecast). In addition, have decided to revise the payment of the year-end dividend to ¥30 per share, an increase of ¥2 per share from the previous forecast which bring the annual dividend to ¥60 per share. As a result, the annual dividend forecast will be ¥60, the DOE ratio will be 4.5%, and together with the share buyback announced, the total return ratio is expected to be 61.2%.
공시 • Aug 27Daicel Corporation to Report Q2, 2025 Results on Nov 07, 2024Daicel Corporation announced that they will report Q2, 2025 results on Nov 07, 2024
공시 • Jun 28Daicel Corporation to Report Q1, 2025 Results on Aug 02, 2024Daicel Corporation announced that they will report Q1, 2025 results on Aug 02, 2024
공시 • May 11Daicel Corporation, Annual General Meeting, Jun 21, 2024Daicel Corporation, Annual General Meeting, Jun 21, 2024.
공시 • May 10+ 1 more updateDaicel Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2024 and Fiscal Year Ending March 31, 2025Daicel Corporation provided consolidated earnings guidance for the six months ending September 30, 2024 and fiscal year ending March 31, 2025. For the six months, the company expects net sales of JPY 295,000 million, operating profit of JPY 32,000 million, profit attributable to owners of parent of JPY 30,000 million and profit per share of JPY 108.77.For the full year, the company expects net sales of JPY 610,000 million, operating profit of JPY 65,000 million, profit attributable to owners of parent of JPY 58,000 million and profit per share of JPY 210.29.
공시 • Mar 28Daicel Corporation to Report Fiscal Year 2024 Results on May 09, 2024Daicel Corporation announced that they will report fiscal year 2024 results on May 09, 2024
공시 • Nov 27Daicel Corporation to Report Q3, 2024 Results on Feb 06, 2024Daicel Corporation announced that they will report Q3, 2024 results on Feb 06, 2024
공시 • Nov 03+ 1 more updateDaicel Corporation (TSE:4202) announces an Equity Buyback for 13,000,000 shares, representing 4.55% for ¥15,000 million.Daicel Corporation (TSE:4202) announces a share repurchase program. Under the program, the company will repurchase up to 13,000,000 shares, representing 4.55% of its issued share capital (excluding treasury stock), for a total purchase price of ¥15,000 million. The purpose of the program is to enhance shareholder returns and improve capital efficiency. The program will be valid till March 31, 2024. As of September 30, 2023, the company had 285,955,394 issued shares (excluding treasury stock) and 987,288 treasury shares.
공시 • Nov 02Daicel Corporation Declares Dividend for the Second Quarter End of the Fiscal Year 2024, Payable on December 4, 2023; Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024Daicel Corporation declared dividend of JPY 25.00 per share for the second quarter end of fiscal year ending March 31, 2024. Scheduled date of payment is December 4, 2023. Record date is September 30, 2023.The company revised year end dividend guidance for the fiscal year ending March 31, 2024. For the period, the company expects to pay dividend of JPY 25.00 per share against the previous guidance of JPY 22.00 per share.
공시 • Sep 24Daicel Corporation to Report Q2, 2024 Results on Nov 02, 2023Daicel Corporation announced that they will report Q2, 2024 results on Nov 02, 2023
공시 • Sep 22Pharma Foods International Co., Ltd. (TSE:2929) agreed to acquire Healthcare Mail Order Business Of Daicel from Daicel Corporation (TSE:4202).Pharma Foods International Co., Ltd. (TSE:2929) agreed to acquire Healthcare Mail Order Business Of Daicel from Daicel Corporation (TSE:4202) on September 20, 2023.
공시 • Jun 28Daicel Corporation to Report Q1, 2024 Results on Aug 03, 2023Daicel Corporation announced that they will report Q1, 2024 results on Aug 03, 2023
공시 • May 12+ 1 more updateDaicel Corporation Announces Year End Dividend for the Year Ended March 31, 2023, Payable on June 26, 2023; Provides Dividend Guidance for the End of Second Quarter and Full Year Ending March 31, 2024Daicel Corporation announced year end dividend of JPY 20.00 per share for the year ended March 31, 2023 compared to JPY 18.00 per share a year ago. Scheduled date for dividend payment: June 26, 2023. The company provided dividend guidance for the end of second quarter and full year ending March 31, 2024. For the end of second quarter, the company expects to pay dividend of JPY 22.00 per share compared to JPY 18.00 per share a year ago. For the full year ending March 31, 2024, the company expects to pay dividend of JPY 22.00 per share compared to JPY 20.00 per share a year ago.
공시 • May 11Daicel Corporation, Annual General Meeting, Jun 23, 2023Daicel Corporation, Annual General Meeting, Jun 23, 2023.
공시 • Feb 03+ 1 more updateDaicel Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023Daicel Corporation provided consolidated earnings guidance for the year ending March 31, 2023. For the year ending March 31, 2023, the company expects net sales of JPY 579,000 million, operating profit of JPY 54,000 million and profit attributable to owners of parent of JPY 41,000 or JPY 138.44 per share.
공시 • Feb 02Daicel Corporation to Report Fiscal Year 2023 Results on May 11, 2023Daicel Corporation announced that they will report fiscal year 2023 results on May 11, 2023
공시 • Dec 28Daicel Corporation to Report Q3, 2023 Results on Feb 02, 2023Daicel Corporation announced that they will report Q3, 2023 results on Feb 02, 2023